Findings can help clinicians personalize treatment.
Large international cohort study of 10,000 patients.
Data are limited regarding patient management after chemotherapy.
An analysis of data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
A multicentre prospective outcome analysis
Findings are from the phase 3 PROTECT trial.
A network meta-analysis compared 6 treatments.
Prospective RACE study compared 2 approaches.
Many believe social media increases patient awareness, education, and access.
QoL analysis from phase 3 HYPO-RT-PC trial.
Routine use of ADT is not recommended for protection against SARS-CoV-2.
Patients on active surveillance should be encouraged to follow a healthy lifestyle.
Study of 2.24 million patients with NSCLC or colon, breast, or prostate cancer.
A new very high-risk group identified.
Secondary analysis of Canadian Cancer Trials Group PR-7 trial.
Findings are from a post hoc analysis of the ARCHES trial.
Rate of pulmonar/wound infections and reinterventions are higher in active smokers.
